Analyzed effects of GLP-1 receptor agonists on patients with type 1 diabetes
Evaluated molecular pathways and biomarkers related to cardiovascular health
Demonstrated significant reduction in cardiovascular events (RR 0.75, 95% CI 0.60-0.94, P=0.02).
Identified improvements in biomarkers associated with cardiovascular health.
Showed favorable effects on molecular pathways linked to cardiovascular risk.
Abstract
Qi Chen, Bilikezi Abuduhelili, Yanyan Xiao, Yuan Chen, Junfei Xu, Chi Chen; GLP-1 receptor agonists in type 1 diabetes: a new frontier for cardiovascular p